Capital World Investors
MPLT

Capital World Investors’s MapLight Therapeutics MPLT Stock Holding History

Capital World Investors’s Portfolio MPLT Stock Details MPLT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.9M Buy
+415,730
New +$12M ﹤0.01% 567

Other funds holding MPLT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $665M AUM 95.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $133B AUM 43.5% 1-Year Est. Return

Capital World Investors's MPLT Position: Q2 2026 in Review

Capital World Investors opened a new position in MapLight Therapeutics (MPLT) in Q2 2026: 415,730 shares worth $14.9M. The stake represents ﹤0.01% of the portfolio and ranks #567 among its holdings.

41 funds tracked by Wall St. Rank hold MPLT as of Q2 2026.

  • Capital World Investors held 415,730 shares of MapLight Therapeutics worth $14.9M as of Q2 2026.
  • MapLight Therapeutics was a new Capital World Investors position in Q2 2026.
  • MapLight Therapeutics made up ﹤0.01% of Capital World Investors's portfolio in Q2 2026, its #567 holding.
  • 41 funds tracked by Wall St. Rank held MapLight Therapeutics as of Q2 2026.

Based on Capital World Investors's 13F filing for Q2 2026, filed 12 Aug 2026.